1 Market Overview of Cancer Immunotherapy Drug Discovery Outsourcing 1.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Overview 1.1.1 Cancer Immunotherapy Drug Discovery Outsourcing Product Scope 1.1.2 Market Status and Outlook 1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2015-2026) 1.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Region (2015-2020) 1.5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) 1.6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) 1.6.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) 1.6.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) 2 Cancer Immunotherapy Drug Discovery Outsourcing Market Overview by Type 2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2015-2020) 2.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2021-2026) 2.4 Type I 2.5 Type II 3 Cancer Immunotherapy Drug Discovery Outsourcing Market Overview by Application 3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2015-2020) 3.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2021-2026) 3.4 Lung 3.5 Breast 3.6 Colorectal 3.7 Melanoma 3.8 Prostate 3.9 Head and Neck 3.10 Ovarian 3.11 Pancreatic 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Competition Analysis by Players 4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2019) 4.3 Date of Key Manufacturers Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market 4.4 Global Top Players Cancer Immunotherapy Drug Discovery Outsourcing Headquarters and Area Served 4.5 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service 4.6 Competitive Status 4.6.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Aquila BioMedical 5.1.1 Aquila BioMedical Profile 5.1.2 Aquila BioMedical Main Business 5.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.1.4 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.1.5 Aquila BioMedical Recent Developments 5.2 BPS Bioscience, Inc. 5.2.1 BPS Bioscience, Inc. Profile 5.2.2 BPS Bioscience, Inc. Main Business 5.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.2.4 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.2.5 BPS Bioscience, Inc. Recent Developments 5.3 Celentyx Ltd 5.5.1 Celentyx Ltd Profile 5.3.2 Celentyx Ltd Main Business 5.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.3.4 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.3.5 Crown Bioscience, Inc. Recent Developments 5.4 Crown Bioscience, Inc. 5.4.1 Crown Bioscience, Inc. Profile 5.4.2 Crown Bioscience, Inc. Main Business 5.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.4.4 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.4.5 Crown Bioscience, Inc. Recent Developments 5.5 DiscoverX Corporation 5.5.1 DiscoverX Corporation Profile 5.5.2 DiscoverX Corporation Main Business 5.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.5.4 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.5.5 DiscoverX Corporation Recent Developments 5.6 Explicyte 5.6.1 Explicyte Profile 5.6.2 Explicyte Main Business 5.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.6.4 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.6.5 Explicyte Recent Developments 5.7 Genscript Biotech Corporation 5.7.1 Genscript Biotech Corporation Profile 5.7.2 Genscript Biotech Corporation Main Business 5.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.7.4 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.7.5 Genscript Biotech Corporation Recent Developments 5.8 HD Biosciences Co. 5.8.1 HD Biosciences Co. Profile 5.8.2 HD Biosciences Co. Main Business 5.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.8.4 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.8.5 HD Biosciences Co. Recent Developments 5.9 Horizon Discovery Group PLC 5.9.1 Horizon Discovery Group PLC Profile 5.9.2 Horizon Discovery Group PLC Main Business 5.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.9.4 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.9.5 Horizon Discovery Group PLC Recent Developments 5.10 ImmunXperts SA 5.10.1 ImmunXperts SA Profile 5.10.2 ImmunXperts SA Main Business 5.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.10.4 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.10.5 ImmunXperts SA Recent Developments 5.11 Molecular Imaging, Inc. 5.11.1 Molecular Imaging, Inc. Profile 5.11.2 Molecular Imaging, Inc. Main Business 5.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.11.4 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.11.5 Molecular Imaging, Inc. Recent Developments 5.12 Promega Corporation,Personalis, Inc. 5.12.1 Promega Corporation,Personalis, Inc. Profile 5.12.2 Promega Corporation,Personalis, Inc. Main Business 5.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.12.4 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.12.5 Promega Corporation,Personalis, Inc. Recent Developments 5.13 STC Biologics 5.13.1 STC Biologics Profile 5.13.2 STC Biologics Main Business 5.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions 5.13.4 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) & (2015-2020) 5.13.5 STC Biologics Recent Developments 6 North America 6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2015-2020) (US$ Million) Table 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Region (2015-2020) Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size Share by Region (2021-2026) Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (US$ Million) Table 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2015-2020) Table 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2021-2026) Table 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (US$ Million) Table 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2015-2020) Table 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2021-2026) Table 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$ Million) by Players (2015-2020) Table 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2019) Table 19. Date of Key Manufacturers Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market Table 20. Global Cancer Immunotherapy Drug Discovery Outsourcing Top Players Headquarters and Area Served Table 21. Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service Table 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Aquila BioMedical Basic Information List Table 25. Aquila BioMedical Description and Business Overview Table 26. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 27. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Aquila BioMedical (2015-2020) Table 28. Aquila BioMedical Recent Developments Table 29. BPS Bioscience, Inc. Basic Information List Table 30. BPS Bioscience, Inc. Description and Business Overview Table 31. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 32. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of BPS Bioscience, Inc. (2015-2020) Table 33. BPS Bioscience, Inc. Recent Developments Table 34. Celentyx Ltd Basic Information List Table 35. Celentyx Ltd Description and Business Overview Table 36. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 37. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Celentyx Ltd (2015-2020) Table 38. Celentyx Ltd Recent Developments Table 39. Crown Bioscience, Inc. Basic Information List Table 40. Crown Bioscience, Inc. Description and Business Overview Table 41. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 42. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Crown Bioscience, Inc. (2015-2020) Table 43. Crown Bioscience, Inc. Recent Developments Table 44. DiscoverX Corporation Basic Information List Table 45. DiscoverX Corporation Description and Business Overview Table 46. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 47. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of DiscoverX Corporation (2015-2020) Table 48. DiscoverX Corporation Recent Developments Table 49. Explicyte Basic Information List Table 50. Explicyte Description and Business Overview Table 51. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 52. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Explicyte (2015-2020) Table 53. Explicyte Recent Developments Table 54. Genscript Biotech Corporation Basic Information List Table 55. Genscript Biotech Corporation Description and Business Overview Table 56. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 57. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Genscript Biotech Corporation (2015-2020) Table 58. Genscript Biotech Corporation Recent Developments Table 59. HD Biosciences Co. Basic Information List Table 60. HD Biosciences Co. Description and Business Overview Table 61. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 62. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of HD Biosciences Co. (2015-2020) Table 63. HD Biosciences Co. Recent Developments Table 64. Horizon Discovery Group PLC Basic Information List Table 65. Horizon Discovery Group PLC Description and Business Overview Table 66. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 67. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Horizon Discovery Group PLC (2015-2020) Table 68. Horizon Discovery Group PLC Recent Developments Table 69. ImmunXperts SA Basic Information List Table 70. ImmunXperts SA Description and Business Overview Table 71. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 72. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of ImmunXperts SA (2015-2020) Table 73. ImmunXperts SA Recent Developments Table 74. Molecular Imaging, Inc. Basic Information List Table 75. Molecular Imaging, Inc. Description and Business Overview Table 76. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 77. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Molecular Imaging, Inc. (2015-2020) Table 78. Molecular Imaging, Inc. Recent Developments Table 79. Promega Corporation,Personalis, Inc. Basic Information List Table 80. Promega Corporation,Personalis, Inc. Description and Business Overview Table 81. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 82. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of Promega Corporation,Personalis, Inc. (2015-2020) Table 83. Promega Corporation,Personalis, Inc. Recent Developments Table 84. STC Biologics Basic Information List Table 85. STC Biologics Description and Business Overview Table 86. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Products, Services and Solutions Table 87. Revenue (Million US$) in Cancer Immunotherapy Drug Discovery Outsourcing Business of STC Biologics (2015-2020) Table 88. STC Biologics Recent Developments Table 89. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2015-2020) & (US$ Million) Table 90. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2015-2020) Table 91. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2015-2020) & (US$ Million) Table 92. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2015-2020) Table 93. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2015-2020) & (US$ Million) Table 94. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Region (2015-2020) (US$ Million) Table 95. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2015-2020) & (US$ Million) Table 96. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2015-2020) (US$ Million) Table 97. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Players (2015-2020) (US$ Million) Table 98. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Players (2015-2020) (US$ Million) Table 99. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends Table 100. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers Table 101. Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges Table 102. Cancer Immunotherapy Drug Discovery Outsourcing Market Restriants Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions: 2020 VS 2026 Figure 4. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type in 2020 & 2026 Figure 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application in 2020 & 2026 Figure 11. Lung Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Breast Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Colorectal Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Melanoma Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Prostate Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Head and Neck Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Top 5 and Top 10 Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share in 2019 Figure 19. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Nordic Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation

Aquila BioMedical BPS Bioscience, Inc. Celentyx Ltd Crown Bioscience, Inc. DiscoverX Corporation Explicyte Genscript Biotech Corporation HD Biosciences Co. Horizon Discovery Group PLC ImmunXperts SA Molecular Imaging, Inc. Promega Corporation,Personalis, Inc. STC Biologics